pentafluoropropane
Small moleculeexperimental
1,1,1,3,3-Pentafluoropropane (HFC-245fa) is a hydrofluorocarbon is a colorless gas used primarily for closed-cell spray foam insulation. HFC-245fa is also known as pentafluoropropane and by its chemical name 1,1,1,3,3-pentafluoropropane. — Wikipedia
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Jan 31, 2020 (NCT04207710)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaPentafluoropropane ↗
Also known as
- pentafluoropropane
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04207710 | Phase 4 | Jan 31, 2020 | Gebauer Company, Henry Ford Health System |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Gebauer Company | For profit | 1 | 0 | 1 | 2020 |
| Henry Ford Health System | Academic/Hospital | 1 | 1 | 1 | 2020 |
2 organizations
Page 1 / 1